O Dreazen

779 total citations
12 papers, 657 citations indexed

About

O Dreazen is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, O Dreazen has authored 12 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 6 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in O Dreazen's work include Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). O Dreazen is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). O Dreazen collaborates with scholars based in United States, Germany and Israel. O Dreazen's co-authors include Eli Canaani, Gale Rp, Robert Peter Gale, Gideon Rechavi, Justus B. Cohen, Amar J. S. Klar, David Givol, Daniela Ram, Christophe Marcelle and Arie Rosner and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

O Dreazen

12 papers receiving 611 citations

Peers

O Dreazen

HEMAT

GENET

MB

PHEOH

RHEUM

Anja Reichert Germany

Valerie Zbrzezna United States

R Maze United States

Thomas M. Trischmann United States

Anne-Catherine Fluckiger France

Dominik Reinhold United States

Taichi Azuma Japan

G.L. Daniels United Kingdom

Tamara Manuelian Germany

Roberta Guglielmino Italy

Anja Reichert Germany

O Dreazen

169 ×0.4

HEMAT

94 ×0.4

GENET

189 ×0.9

MB

64 ×0.5

PHEOH

46 ×0.5

RHEUM

Citations per year, relative to O Dreazen O Dreazen (= 1×) peers Anja Reichert

Countries citing papers authored by O Dreazen

Since Specialization

Citations

This map shows the geographic impact of O Dreazen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Dreazen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Dreazen more than expected).

Fields of papers citing papers by O Dreazen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Dreazen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Dreazen. The network helps show where O Dreazen may publish in the future.

Co-authorship network of co-authors of O Dreazen

This figure shows the co-authorship network connecting the top 25 collaborators of O Dreazen. A scholar is included among the top collaborators of O Dreazen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Dreazen. O Dreazen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Reiter‐Owona, Ingrid, Eskild Petersen, D. H. M. Joynson, et al.. (1999). The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis.. PubMed. 77(11). 929–35. 83 indexed citations

2.

Miller, Carl W., et al.. (1989). A Ph1 chromosome positive B cell line expresses the fusion protein P 210.. PubMed. 31(1). 39–43. 1 indexed citations

3.

Li, Wen J., et al.. (1989). Characterization of bcr gene products in hematopoietic cells.. PubMed. 4(2). 127–38. 35 indexed citations

4.

Rassool, Feyruz V., Letizia Foroni, Amin Rahemtulla, et al.. (1988). The genomic breakpoint in a patient with Philadelphia-positive acute leukemia is 5′ of the breakpoint cluster region. Cancer Genetics and Cytogenetics. 32(2). 217–227. 3 indexed citations

5.

Dreazen, O, Ivana Klisak, Feyruz V. Rassool, et al.. (1988). The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.. PubMed. 2(2). 167–75. 2 indexed citations

6.

Dreazen, O, Eli Canaani, & Gale Rp. (1988). Molecular biology of chronic myelogenous leukemia.. PubMed. 25(1). 35–48. 43 indexed citations

7.

Sa, Feig, O Dreazen, M. Simón, et al.. (1988). B cell acute lymphoblastic leukemia (ALL) in donor cells following bone marrow transplantation for T cell ALL.. PubMed. 3(4). 331–7. 25 indexed citations

8.

Marcelle, Christophe, Arie Rosner, Eli Canaani, et al.. (1987). A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature. 330(6146). 386–388. 159 indexed citations

9.

Shtivelman, Emma, Gale Rp, O Dreazen, et al.. (1987). bcr-abl RNA in patients with chronic myelogenous leukemia. Blood. 69(3). 971–973. 84 indexed citations

10.

Dreazen, O, Ivana Klisak, Gary E. Jones, et al.. (1987). Multiple molecular abnormalities in Ph¹ chromosome positive acute lymphoblastic leukaemia. British Journal of Haematology. 67(3). 319–324. 24 indexed citations

11.

Dreazen, O, Feyruz V. Rassool, RobertS. Sparkes, et al.. (1987). DO ONCOGENES DETERMINE CLINICAL FEATURES IN CHRONIC MYELOID LEUKAEMIA?. The Lancet. 329(8547). 1402–1405. 51 indexed citations

12.

Canaani, Eli, O Dreazen, Amar J. S. Klar, et al.. (1983). Activation of the c-mos oncogene in a mouse plasmacytoma by insertion of an endogenous intracisternal A-particle genome.. Proceedings of the National Academy of Sciences. 80(23). 7118–7122. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact